The COVID-19 pandemic exposed significant vulnerabilities in global pharmaceutical supply chains, particularly regarding the availability of active pharmaceutical ingredients (APIs)—the essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback